AAAAAA

   
Results: 1-10 |
Results: 10
Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
Authors: Tabone, MD Landman-Parker, J Arcil, B Coudert, MC Gerota, I Benbunan, M Leverger, G Bosquet, C
Citation: Md. Tabone et al., Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?, CLIN CANC R, 7(3), 2001, pp. 538-543
Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation
Authors: Hiesse, C Busson, M Buisson, C Farahmand, H Bierling, P Benbunan, M Bedrossian, J Aubert, P Glotz, D Loirat, C Rondeau, E Viron, B Bleux, H Lang, P
Citation: C. Hiesse et al., Multicenter trial of one HLA-DR-matched or mismatched blood transfusion prior to cadaveric renal transplantation, KIDNEY INT, 60(1), 2001, pp. 341-349
Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilization
Authors: Dosquet, C Chen, Y Makke, J Miclea, JM Coudert, MC Marolleau, JP Fermand, JP Cottu, P Lotz, JP Benbunan, M
Citation: C. Dosquet et al., Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilization, TRANSFUSION, 41(2), 2001, pp. 206-212
Cord blood banking: Volume reduction using "Procord" Terumo filter
Authors: Dal Cortivo, L Robert, I Mangin, C Sameshima, T Kora, S Gluckman, E Benbunan, M Marolleau, JP
Citation: L. Dal Cortivo et al., Cord blood banking: Volume reduction using "Procord" Terumo filter, J HEMATH ST, 9(6), 2000, pp. 885-890
Conservation of red blood cells in heterozygous SC sickle cell patients.
Authors: Lasserre, J Maury, J Lefevre, G Max-Audit, I Bimet, C Maier-Redelsperger, M Etienne, J Rain, JD Adam, E Benbunan, M Girot, R
Citation: J. Lasserre et al., Conservation of red blood cells in heterozygous SC sickle cell patients., TRANSF CL B, 7(2), 2000, pp. 119-128
Cell therapy: perspectives for curing skin wounds?
Authors: Senet, P Coulomb, B Benbunan, M Meaume, S Dubertret, L Dosquet, C
Citation: P. Senet et al., Cell therapy: perspectives for curing skin wounds?, ANN DER VEN, 127(8-9), 2000, pp. 765-766
CD34+cells during leukapheresis procedures: relationship of volume processed and quantity of peripheral blood progenitor cells collected
Authors: Lefrere, F Makki, J Marolleau, JP Dal Cortivo, L Alberti, C Benbunan, M Miclea, JM
Citation: F. Lefrere et al., CD34+cells during leukapheresis procedures: relationship of volume processed and quantity of peripheral blood progenitor cells collected, TRANSFUSION, 40(4), 2000, pp. 493-495
Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma
Authors: Lefrere, F Makke, J Fermand, JP Marolleau, JP Dal Cortivo, L Alberti, C Mouton, V Benbunan, M Miclea, JM
Citation: F. Lefrere et al., Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma, BONE MAR TR, 24(5), 1999, pp. 463-466
Enrichment of peripheral blood CD34(+) cells for transplantation using a fully automated immunomagnetic cell selection system and a novel octapeptidereleasing agent
Authors: Marolleau, JP Dal Cortivo, L Mills, B Fermand, JP Miclea, JM Lotz, JP Gisselbrecht, C Benbunan, M
Citation: Jp. Marolleau et al., Enrichment of peripheral blood CD34(+) cells for transplantation using a fully automated immunomagnetic cell selection system and a novel octapeptidereleasing agent, BONE MAR TR, 23(8), 1999, pp. 819-826
A novel retrovirus vector derived from Fr-MuLV FB29 mediating transductionof haematopoietic cells
Authors: Cohen-Haguenauer, O Masset, M Carteau, AE Setterblad, N Kazal, I Bedel, JF Demerens, C Dal Cortivo, L Marolleau, JP Benbunan, M Boiron, M Peault, B Marty, M
Citation: O. Cohen-haguenauer et al., A novel retrovirus vector derived from Fr-MuLV FB29 mediating transductionof haematopoietic cells, EUROCANCER 98, 1998, pp. 293-294
Risultati: 1-10 |